A Phase 3b, Open-Label, Single-Arm, Rollover Study to Evaluate Long-Term Safety in Subjects who have participated in other Luspatercept (ACE-536) Clinical Trials

Project: Research

Project Details

StatusActive
Effective start/end date1/11/1931/10/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 3 study
  • thalassaemia